Ignite Creation Date:
2025-12-25 @ 12:21 AM
Ignite Modification Date:
2026-02-20 @ 8:15 PM
Study NCT ID:
NCT00094458
Status:
COMPLETED
Last Update Posted:
2017-02-09
First Post:
2004-10-19
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Trial Comparing Infliximab and Infliximab and Azathioprine in the Treatment of Patients With Crohn's Disease na�ve to Both Immunomodulators and Biologic Therapy (Study of Biologic and Immunomodulator Naive Patients in Chrohn's Disease: SONIC
Sponsor:
Centocor Ortho Biotech Services, L.L.C.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
CR004804
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |